Lv2
150 积分 2025-03-26 加入
Discovery of Reversible Covalent Bruton’s Tyrosine Kinase Inhibitors PRN473 and PRN1008 (Rilzabrutinib)
15小时前
已完结
Recent Developments in PROTAC‐Mediated Protein Degradation: From Bench to Clinic
3天前
已完结
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
3天前
已完结
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models
9天前
已完结
T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura
1个月前
已完结
CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura
1个月前
已完结
Spleen Is a Primary Site for Activation of Platelet-Reactive T and B Cells in Patients with Immune Thrombocytopenic Purpura
1个月前
已完结
Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art
1个月前
已完结
Effects of orelabrutinib, a BTK inhibitor, on antibody‐mediated platelet destruction in primary immune thrombocytopenia
1个月前
已完结
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma
2个月前
已完结
皖公网安备34019202002308
